Healthcare-associated infections in critical COVID-19 patients in Tunis: epidemiology, risk factors, and outcomes
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background: Coronavirus disease 2019 (COVID-19) pandemic disrupted adherences to healthcare-associated infection (HAI) prevention protocols. Herein, we studied the characteristics of all HAIs occurring in critically ill COVID-19 patients. Methods: A retrospective, single-center cohort of critical COVID-19 patients during 2021. Microbiological samples were collected if HAI was suspected. We analyzed all factors that could potentially induce HAI, using septic shock and mortality as endpoints. Results: Sixty-four among 161 included patients (39.7%) presented a total of 117 HAIs with an incidence density of 69.2 per 1,000 hospitalization days. Compared to the prior COVID-19 period (2013–2019), the identification of HAI increased in 2021. HAIs were classified into ventilator-associated pneumonia (VAP; n=38), bloodstream infection (n=32), urinary tract infection (n=24), catheter-related infection (n=12), and fungal infection (n=11). All HAIs occurred significantly earlier in the post–COVID-19 period (VAP: 6 vs. 10 days, P=0.045, in 2017 and 2021). Acinetobacter baumannii (39.5%) and Klebsiella pneumoniae (27%) were the most commonly isolated pathogens that exhibited a multidrug-resistant (MDR) profile, observed in 89% and 64.5%, respectively. The HAI factors were laboratory abnormalities (odds ratio [OR], 6.4; 95% confidence interval [CI], 2.3–26.0), cumulative steroid dose (OR, 1.9; 95% CI, 1.3–4.0), and invasive procedures (OR, 20.7; 95% CI, 5.3–64.0). HAI was an independent factor of mortality (OR, 8.5; P=0.004). Conclusions: During the COVID-19 era, the incidence of HAIs increased and MDR isolates remained frequent. A severe biological inflammatory syndrome, invasive devices, and elevated cumulative steroid dosages were related to HAIs. HAI was a significant death factor.
Abstract
Background: Coronavirus disease 2019 (COVID-19) pandemic disrupted adherences to healthcare-associated infection (HAI) prevention protocols. Herein, we studied the characteristics of all HAIs occurring in critically ill COVID-19 patients. Methods: A retrospective, single-center cohort of critical COVID-19 patients during 2021. Microbiological samples were collected if HAI was suspected. We analyzed all factors that could potentially induce HAI, using septic shock and mortality as endpoints. Results: Sixty-four among 161 included patients (39.7%) presented a total of 117 HAIs with an incidence density of 69.2 per 1,000 hospitalization days. Compared to the prior COVID-19 period (2013–2019), the identification of HAI increased in 2021. HAIs were classified into ventilator-associated pneumonia (VAP; n=38), bloodstream infection (n=32), urinary tract infection (n=24), catheter-related infection (n=12), and fungal infection (n=11). All HAIs occurred significantly earlier in the post–COVID-19 period (VAP: 6 vs. 10 days, P=0.045, in 2017 and 2021). Acinetobacter baumannii (39.5%) and Klebsiella pneumoniae (27%) were the most commonly isolated pathogens that exhibited a multidrug-resistant (MDR) profile, observed in 89% and 64.5%, respectively. The HAI factors were laboratory abnormalities (odds ratio [OR], 6.4; 95% confidence interval [CI], 2.3–26.0), cumulative steroid dose (OR, 1.9; 95% CI, 1.3–4.0), and invasive procedures (OR, 20.7; 95% CI, 5.3–64.0). HAI was an independent factor of mortality (OR, 8.5; P=0.004). Conclusions: During the COVID-19 era, the incidence of HAIs increased and MDR isolates remained frequent. A severe biological inflammatory syndrome, invasive devices, and elevated cumulative steroid dosages were related to HAIs. HAI was a significant death factor.
참고문헌 (30)
- Huang C, "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China", Lancet, 395, pp.497~506 (2020)
- Conway Morris A, "Co-infection and ICU-acquired infection in COIVD-19 ICU patients : a secondary analysis of the UNITE-COVID data set", Crit Care, 26, pp.236~ (2022)
- Despotovic A, "Hospital-acquired infections in the adult intensive care unit-Epidemiology, antimicrobial resistance patterns, and risk factors for acquisition and mortality", Am J Infect Control, 48, pp.1211~1215 (2020)
- Barrasa H, "High rate of infections during ICU admission of patients with severe SARS-CoV-2 pneumonia : a matter of time?", J Infect, 82, pp.186~230 (2021)
- Lansbury L, "Co-infections in people with COVID-19 : a systematic review and meta-analysis", J Infect, 81, pp.266~275 (2020)
- Contou D, "Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU", Ann Intensive Care, 10, pp.119~ (2020)
- Hanson KE, "Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): serologic testing", Clin Infect Dis, pp.ciaa1343~ (2020)
- Trifi A, "Nosocomial infections : current situation in a resuscitation-unit", Tunis Med, 95, pp.179~184 (2017)
- Schwendimann R, "The occurrence, types, consequences and preventability of in-hospital adverse events : a scoping review", BMC Health Serv Res, 18, pp.521~ (2018)
- "Patient safety fact file" (2019)[URL]
- Haque M, "Health care-associated infections : an overview", Infect Drug Resist, 11, pp.2321~2333 (2018)
- Peters A, "2019 WHO hand hygiene campaign and global survey : clean care for all-it's in your hands", Lancet Infect Dis, 19, pp.463~464 (2019)
- Saito H, "2018 WHO hand hygiene campaign : preventing sepsis in health care and the path to universal health coverage", Lancet Infect Dis, 18, pp.490~492 (2018)
- Roshan R, "Rigorous hand hygiene practices among health care workers reduce hospital-associated infections during the COVID-19 pandemic", J Prim Care Community Health, 11, pp.2150132720943331~ (2020)
- Baccolini V, "The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients : a retrospective cohort study", Antimicrob Resist Infect Control, 10, pp.87~ (2021)
- Petty LA, "Risk factors and outcomes associated with community-onset and hospital-acquired coinfection in patients hospitalized for coronavirus disease 2019(COVID-19) : a multihospital cohort study", Infect Control Hosp Epidemiol, 43, pp.1184~1193 (2022)
- Somers EC, "Tocilizumab for treatment of mechanically ventilated patients with COVID-19", Clin Infect Dis, 73, pp.e445~54 (2021)
- He Y, "Nosocomial infection among patients with COVID-19 : a retrospective data analysis of 918 cases from a single center in Wuhan, China", Infect Control Hosp Epidemiol, 41, pp.982~983 (2020)
- Soriano MC, "Low incidence of co-infection, but high incidence of ICU-acquired infections in critically ill patients with COVID-19", J Infect, 82, pp.e20~1 (2021)
- Grasselli G, "Hospital-acquired infections in critically ill patients with COVID-19", Chest, 160, pp.454~465 (2021)
- Wiersinga WJ, "Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019(COVID-19) : a review", JAMA, 324, pp.782~793 (2020)
- Luyt CE, "Pulmonary infections complicating ARDS", Intensive Care Med, 46, pp.2168~2183 (2020)
- Kokkoris S, "ICU-acquired bloodstream infections in critically ill patients with COVID-19", J Hosp Infect, 107, pp.95~97 (2021)
- Falcone M, "Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19 : a prospective observational study", J AntimicrobChemother, 76, pp.1078~1084 (2021)
- Bardi T, "Nosocomial infections associated to COVID-19 in the intensive care unit : clinical characteristics and outcome", Eur J Clin Microbiol Infect Dis, 40, pp.495~502 (2021)
- Garcia-Vidal C, "Incidence of co-infections and superinfections in hospitalized patients with COVID-19 : a retrospective cohort study", Clin Microbiol Infect, 27, pp.83~88 (2021)
- Cheng K, "Analysis of the risk factors for nosocomial bacterial infection in patients with COVID-19 in a tertiary hospital", Risk Manag Healthc Policy, 13, pp.2593~2599 (2020)
- Kyi M, "Early intervention for diabetes in medical and surgical inpatients decreases hyperglycemia and hospital-acquired infections : a cluster randomized trial", Diabetes Care, 42, pp.832~840 (2019)
- Khaodhiar L, "Perioperative hyperglycemia, infection or risk?", Curr Opin Clin Nutr Metab Care, 2, pp.79~82 (1999)
- Ruan Q, "Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China", Intensive Care Med, 46, pp.846~848 (2020)